Saugstad Ola Didrik, Aune Dagfinn
Department of Pediatric Research, Oslo University Hospital, University of Oslo, Oslo, Norway.
Neonatology. 2014;105(1):55-63. doi: 10.1159/000356561. Epub 2013 Nov 15.
The optimal oxygen saturation for extremely low birth weight infants in the postnatal period beyond the delivery room is not known.
To summarize and discuss the results of the randomized trials, constituting the NEOPROM (Neonatal Oxygenation Prospective Meta-analysis) collaborative study, examining the effect of low versus high functional oxygen saturation targets in the postnatal period in premature infants with gestational age <28 weeks.
A meta-analysis of SUPPORT (Surfactant, Positive Pressure and Pulse Oximetry Randomized Trial), the three BOOST II (Benefits of Oxygen Saturation Targeting) studies and the COT (Canadian Oxygen Trial) was performed including a total of 4,911 infants randomized to either a low (85-89%) or high (91-95%) functional oxygen saturation (SpO2) within the first 24 h after birth.
Relative risks (RR; 95% CIs) comparing a low versus a high oxygen saturation target were 1.41 (1.14-1.74) for mortality at discharge or at follow-up, 0.74 (0.59-0.92) for severe retinopathy of prematurity, 0.95 (0.86-1.04) for physiologic bronchopulmonary dysplasia, 1.25 (1.05-1.49) for necrotizing enterocolitis, 1.02 (0.88-1.19) for brain injury, and 1.01 (0.95-1.08) for patent ductus arteriosus. RR >1.0 favors a high oxygen saturation.
RRs for mortality and necrotizing enterocolitis are significantly increased and severe retinopathy of prematurity significantly reduced in low compared to high oxygen saturation target infants. There are no differences regarding physiologic bronchopulmonary dysplasia, brain injury or patent ductus arteriosus between the groups. Based on these results, it is suggested that functional SpO2 should be targeted at 90-95% in infants with gestational age <28 weeks until 36 weeks' postmenstrual age. However, there are still several unanswered questions in this field.
出生后产房外极低出生体重儿的最佳氧饱和度尚不清楚。
总结并讨论构成NEOPROM(新生儿氧合前瞻性荟萃分析)合作研究的随机试验结果,该研究探讨了出生后胎龄<28周的早产儿低功能氧饱和度目标与高功能氧饱和度目标的效果。
对SUPPORT(表面活性剂、正压通气和脉搏血氧饱和度随机试验)、三项BOOST II(氧饱和度目标的益处)研究以及COT(加拿大氧疗试验)进行荟萃分析,共纳入4911例婴儿,这些婴儿在出生后24小时内被随机分为低(85%-89%)或高(91%-95%)功能氧饱和度(SpO2)组。
比较低氧饱和度目标与高氧饱和度目标的相对风险(RR;95%CI),出院时或随访时死亡率为1.41(1.14-1.74),重度早产儿视网膜病变为0.74(0.59-0.92),生理性支气管肺发育不良为0.95(0.86-1.04),坏死性小肠结肠炎为1.25(1.05-1.49),脑损伤为1.02(0.88-1.19),动脉导管未闭为1.01(0.95-1.08)。RR>1.0表明高氧饱和度更有利。
与高氧饱和度目标婴儿相比,低氧饱和度目标婴儿的死亡率和坏死性小肠结肠炎的RR显著增加,重度早产儿视网膜病变的RR显著降低。两组在生理性支气管肺发育不良、脑损伤或动脉导管未闭方面无差异。基于这些结果,建议胎龄<28周的婴儿在月经后年龄36周之前,功能SpO2目标应为90%-95%。然而,该领域仍有几个未解决的问题。